Skip to main content

Peer Review reports

From: Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial

Original Submission
5 Oct 2021 Submitted Original manuscript
24 Oct 2021 Reviewed Reviewer Report
14 Nov 2021 Reviewed Reviewer Report - Claudio Cerchione
30 Nov 2021 Author responded Author comments - Karen Dybkær
7 Dec 2021 Author responded Author comments - Karen Dybkær
Resubmission - Version 2
30 Nov 2021 Submitted Manuscript version 2
14 Dec 2021 Author responded Author comments - Karen Dybkær
Resubmission - Version 3
14 Dec 2021 Submitted Manuscript version 3
22 Dec 2021 Author responded Author comments - Karen Dybkær
Resubmission - Version 4
22 Dec 2021 Submitted Manuscript version 4
Publishing
7 Jan 2022 Editorially accepted
5 Feb 2022 Article published 10.1186/s12885-022-09184-1

You can find further information about peer review here.

Back to article page